BBC icon

Virtus LifeSci Biotech Clinical Trials ETF

17 hedge funds and large institutions have $2.11M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$643K
2 +$8.24K
3 +$350

Top Sellers

1 -$1.03M
2 -$913K
3 -$21.9K
4
DI
DAGCO Inc
Ohio
-$19.6K
5
LPL Financial
LPL Financial
California
-$5.86K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.17M
2
$420K
3
$360K
4
$29.1K
5
$24.4K
6
$23K
7
$21.9K
8
$20.3K
9
$13K
10
$9.03K
11
$8.24K
12
$2.91K
13
$1.59K
14
$1.28K
15
$350
16
$292
17
$146
18
19
20